PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 16, 2025Pharmaceuticals3 citationsOpen Access

Advances in Modeling the Inner Blood–Retinal Barrier: From Static Tissue Cell Cultures to Microphysiological Systems

View Full Paper
AAAikaterini ApostolidiGSGeorgios StergiopoulosSBSofia Bellou

Key Points

  • Microphysiological systems replicate essential aspects of the inner blood–retinal barrier, enhancing research accuracy.
  • Sophisticated cell culture techniques evolve from simple monolayers to complex multicellular systems, addressing previous modeling limitations.
  • Cell-based in vitro modeling is crucial for understanding iBRB function and dysfunction in various ocular conditions.
  • These innovative models serve as valuable tools for drug screening and improving translational outcomes in ophthalmic research.

Abstract

Background/Objectives: The inner blood–retinal barrier (iBRB) is a specialized neurovascular interface essential for retinal homeostasis and visual function and is compromised in several vision-threating conditions. Therefore, the ability to model iBRB function and dysfunction in a controlled, reproducible and scalable manner is crucial for pharmaceutical research. However, the complex anatomy and physiology of the iBRB raise challenges for cell-based in vitro modeling. Methods/Results: This review follows the evolution of iBRB models—from simple monolayers of retinal endothelial cells (ECs) to sophisticated multicellular microphysiological systems (MPs). Advanced diverse microfluidic platforms aim to replicate key structural, biochemical and functional aspects of the iBRB, each incorporating distinct strategies regarding cell sourcing, device design, flow dynamics and functional readouts. Conclusions: Despite their limitations, these models are highly valuable for drug screening and mechanistic studies aimed at preserving or restoring barrier integrity while also helping to bridge the translational gap in ophthalmic drug discovery.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Apostolidi et al. (2025) studied this question.

synapsesocial.com/papers/68d4508931b076d99fa58729https://doi.org/10.3390/ph18091374
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Blood-retina barrier dysfunction in experimental autoimmune uveitis: the pathogenesis and therapeutic targets2022 · 22 citations
  2. 2Potential Role of Microglia in Retinal Blood Vessel Formation2006 · 381 citations
  3. 3Efficacy and prognostic factors of anti-VEGF treatment for neovascular age-related macular degeneration: An OCTA imaging-based deep learning analysis2025 · 5 citations
  4. 4Glia–neuron interactions in the mammalian retina2015 · 857 citations
  5. 5Retinal Organoids: A Next-Generation Platform for High-Throughput Drug Discovery2023 · 45 citations